ID PRXC_CURIN Reviewed; 609 AA. AC P49053; DT 01-FEB-1996, integrated into UniProtKB/Swiss-Prot. DT 01-FEB-1996, sequence version 1. DT 27-MAR-2024, entry version 111. DE RecName: Full=Vanadium chloroperoxidase {ECO:0000303|PubMed:7744081}; DE EC=1.11.1.10 {ECO:0000269|PubMed:7744081}; DE AltName: Full=Vanadium chloride peroxidase; DE Short=VCPO; GN Name=CPO; OS Curvularia inaequalis. OC Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Dothideomycetes; OC Pleosporomycetidae; Pleosporales; Pleosporineae; Pleosporaceae; Curvularia. OX NCBI_TaxID=38902; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, FUNCTION, CATALYTIC RP ACTIVITY, COFACTOR, SUBCELLULAR LOCATION, DEVELOPMENTAL STAGE, AND SUBUNIT. RX PubMed=7744081; DOI=10.1111/j.1432-1033.1995.tb20499.x; RA Simons B.H., Barnett P., Vollenbroek E.G.M., Dekker H.L., Muijsers A.O., RA Messerschmidt A., Wever R.; RT "Primary structure and characterization of the vanadium chloroperoxidase RT from the fungus Curvularia inaequalis."; RL Eur. J. Biochem. 229:566-574(1995). RN [2] {ECO:0007744|PDB:1VNC} RP X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) IN COMPLEX WITH VANADATE, COFACTOR, RP REACTION MECHANISM, AND ACTIVE SITE. RX PubMed=8552646; DOI=10.1073/pnas.93.1.392; RA Messerschmidt A., Wever R.; RT "X-ray structure of a vanadium-containing enzyme: chloroperoxidase from the RT fungus Curvularia inaequalis."; RL Proc. Natl. Acad. Sci. U.S.A. 93:392-396(1996). RN [3] {ECO:0007744|PDB:1IDQ, ECO:0007744|PDB:1IDU} RP X-RAY CRYSTALLOGRAPHY (2.03 ANGSTROMS) IN COMPLEX WITH VANADATE, COFACTOR, RP AND REACTION MECHANISM. RX PubMed=9165086; DOI=10.1515/bchm.1997.378.3-4.309; RA Messerschmidt A., Prade L., Wever R.; RT "Implications for the catalytic mechanism of the vanadium-containing enzyme RT chloroperoxidase from the fungus Curvularia inaequalis by X-ray structures RT of the native and peroxide form."; RL Biol. Chem. 378:309-315(1997). CC -!- FUNCTION: Catalyzes the oxidation of chloride in the presence of CC hydrogen peroxide to hypochlorous acid (ClOH), which in turn can react CC with a nucleophilic acceptor (RH), to form a chlorinated compound. CC {ECO:0000269|PubMed:7744081}. CC -!- CATALYTIC ACTIVITY: CC Reaction=RH + Cl(-) + H2O2 = RCl + 2 H2O.; EC=1.11.1.10; CC Evidence={ECO:0000269|PubMed:7744081}; CC -!- COFACTOR: CC Name=vanadate; Xref=ChEBI:CHEBI:35169; CC Evidence={ECO:0000269|PubMed:8552646, ECO:0000269|PubMed:9165086, CC ECO:0000305|PubMed:7744081}; CC -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:7744081}. CC -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:7744081}. CC -!- DEVELOPMENTAL STAGE: Expression takes place in the secondary-growth CC phase initiated by nutrient depletion. {ECO:0000269|PubMed:7744081}. CC -!- PTM: The N-terminus is blocked. {ECO:0000269|PubMed:7744081}. CC -!- SIMILARITY: Belongs to the vanadium-dependent haloperoxidase family. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; X85369; CAA59686.1; -; mRNA. DR PIR; S69334; S69334. DR PDB; 1IDQ; X-ray; 2.03 A; A=1-609. DR PDB; 1IDU; X-ray; 2.24 A; A=1-609. DR PDB; 1VNC; X-ray; 2.10 A; A=1-609. DR PDB; 1VNE; X-ray; 2.15 A; A=1-609. DR PDB; 1VNF; X-ray; 2.35 A; A=1-609. DR PDB; 1VNG; X-ray; 2.20 A; A=1-609. DR PDB; 1VNH; X-ray; 2.11 A; A=1-609. DR PDB; 1VNI; X-ray; 2.15 A; A=1-609. DR PDB; 1VNS; X-ray; 1.66 A; A=1-609. DR PDB; 3BB0; X-ray; 1.50 A; A=1-609. DR PDBsum; 1IDQ; -. DR PDBsum; 1IDU; -. DR PDBsum; 1VNC; -. DR PDBsum; 1VNE; -. DR PDBsum; 1VNF; -. DR PDBsum; 1VNG; -. DR PDBsum; 1VNH; -. DR PDBsum; 1VNI; -. DR PDBsum; 1VNS; -. DR PDBsum; 3BB0; -. DR AlphaFoldDB; P49053; -. DR SMR; P49053; -. DR PeroxiBase; 5892; CinaVCPo. DR KEGG; ag:CAA59686; -. DR BioCyc; MetaCyc:MONOMER-15997; -. DR BRENDA; 1.11.1.B2; 1761. DR SABIO-RK; P49053; -. DR EvolutionaryTrace; P49053; -. DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell. DR GO; GO:0016691; F:chloride peroxidase activity; IEA:UniProtKB-EC. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR CDD; cd03398; PAP2_haloperoxidase; 1. DR Gene3D; 1.20.144.10; Phosphatidic acid phosphatase type 2/haloperoxidase; 1. DR Gene3D; 1.10.606.10; Vanadium-containing Chloroperoxidase, domain 2; 1. DR InterPro; IPR016119; Br/Cl_peroxidase_C. DR InterPro; IPR036938; P_Acid_Pase_2/haloperoxi_sf. DR InterPro; IPR041067; VCPO_N. DR PANTHER; PTHR34599; PEROXIDASE-RELATED; 1. DR PANTHER; PTHR34599:SF1; TRAF-TYPE DOMAIN-CONTAINING PROTEIN; 1. DR Pfam; PF17897; VCPO_N; 1. DR SUPFAM; SSF48317; Acid phosphatase/Vanadium-dependent haloperoxidase; 1. PE 1: Evidence at protein level; KW 3D-structure; Chloride; Direct protein sequencing; Metal-binding; KW Oxidoreductase; Peroxidase; Secreted; Vanadium. FT CHAIN 1..609 FT /note="Vanadium chloroperoxidase" FT /id="PRO_0000097055" FT REGION 569..609 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT ACT_SITE 404 FT /note="Proton donor" FT /evidence="ECO:0000305|PubMed:8552646" FT BINDING 353 FT /ligand="vanadate" FT /ligand_id="ChEBI:CHEBI:35169" FT /evidence="ECO:0000269|PubMed:8552646, FT ECO:0000269|PubMed:9165086, ECO:0007744|PDB:1IDQ, FT ECO:0007744|PDB:1VNC" FT BINDING 360 FT /ligand="vanadate" FT /ligand_id="ChEBI:CHEBI:35169" FT /evidence="ECO:0000269|PubMed:8552646, FT ECO:0000269|PubMed:9165086, ECO:0007744|PDB:1IDQ, FT ECO:0007744|PDB:1VNC" FT BINDING 402 FT /ligand="vanadate" FT /ligand_id="ChEBI:CHEBI:35169" FT /evidence="ECO:0000269|PubMed:8552646, FT ECO:0000269|PubMed:9165086, ECO:0007744|PDB:1IDQ, FT ECO:0007744|PDB:1VNC" FT BINDING 403 FT /ligand="vanadate" FT /ligand_id="ChEBI:CHEBI:35169" FT /evidence="ECO:0000269|PubMed:8552646, FT ECO:0000269|PubMed:9165086, ECO:0007744|PDB:1IDQ, FT ECO:0007744|PDB:1VNC" FT BINDING 404 FT /ligand="vanadate" FT /ligand_id="ChEBI:CHEBI:35169" FT /evidence="ECO:0000269|PubMed:8552646, FT ECO:0000269|PubMed:9165086, ECO:0007744|PDB:1IDQ, FT ECO:0007744|PDB:1VNC" FT BINDING 490 FT /ligand="vanadate" FT /ligand_id="ChEBI:CHEBI:35169" FT /evidence="ECO:0000269|PubMed:8552646, FT ECO:0000269|PubMed:9165086, ECO:0007744|PDB:1IDQ, FT ECO:0007744|PDB:1VNC" FT BINDING 496 FT /ligand="vanadate" FT /ligand_id="ChEBI:CHEBI:35169" FT /evidence="ECO:0000269|PubMed:8552646, FT ECO:0000269|PubMed:9165086, ECO:0007744|PDB:1IDQ, FT ECO:0007744|PDB:1VNC" FT CONFLICT 454 FT /note="P -> S (in Ref. 1; AA sequence)" FT /evidence="ECO:0000305" FT HELIX 16..20 FT /evidence="ECO:0007829|PDB:3BB0" FT HELIX 22..40 FT /evidence="ECO:0007829|PDB:3BB0" FT HELIX 47..68 FT /evidence="ECO:0007829|PDB:3BB0" FT STRAND 72..74 FT /evidence="ECO:0007829|PDB:3BB0" FT STRAND 77..79 FT /evidence="ECO:0007829|PDB:3BB0" FT HELIX 85..87 FT /evidence="ECO:0007829|PDB:3BB0" FT HELIX 98..114 FT /evidence="ECO:0007829|PDB:3BB0" FT TURN 118..125 FT /evidence="ECO:0007829|PDB:1VNS" FT HELIX 131..147 FT /evidence="ECO:0007829|PDB:3BB0" FT HELIX 157..173 FT /evidence="ECO:0007829|PDB:3BB0" FT TURN 176..179 FT /evidence="ECO:0007829|PDB:3BB0" FT STRAND 202..207 FT /evidence="ECO:0007829|PDB:3BB0" FT STRAND 215..218 FT /evidence="ECO:0007829|PDB:3BB0" FT HELIX 226..229 FT /evidence="ECO:0007829|PDB:3BB0" FT HELIX 248..250 FT /evidence="ECO:0007829|PDB:3BB0" FT HELIX 254..268 FT /evidence="ECO:0007829|PDB:3BB0" FT HELIX 280..288 FT /evidence="ECO:0007829|PDB:3BB0" FT TURN 295..297 FT /evidence="ECO:0007829|PDB:3BB0" FT HELIX 300..314 FT /evidence="ECO:0007829|PDB:3BB0" FT STRAND 317..319 FT /evidence="ECO:0007829|PDB:3BB0" FT STRAND 321..323 FT /evidence="ECO:0007829|PDB:3BB0" FT HELIX 325..356 FT /evidence="ECO:0007829|PDB:3BB0" FT HELIX 361..366 FT /evidence="ECO:0007829|PDB:3BB0" FT TURN 371..373 FT /evidence="ECO:0007829|PDB:3BB0" FT STRAND 388..390 FT /evidence="ECO:0007829|PDB:3BB0" FT HELIX 403..419 FT /evidence="ECO:0007829|PDB:3BB0" FT TURN 420..422 FT /evidence="ECO:0007829|PDB:3BB0" FT STRAND 436..440 FT /evidence="ECO:0007829|PDB:3BB0" FT STRAND 444..447 FT /evidence="ECO:0007829|PDB:3BB0" FT STRAND 449..453 FT /evidence="ECO:0007829|PDB:3BB0" FT HELIX 461..463 FT /evidence="ECO:0007829|PDB:3BB0" FT STRAND 466..468 FT /evidence="ECO:0007829|PDB:3BB0" FT STRAND 473..477 FT /evidence="ECO:0007829|PDB:3BB0" FT HELIX 479..492 FT /evidence="ECO:0007829|PDB:3BB0" FT HELIX 498..501 FT /evidence="ECO:0007829|PDB:3BB0" FT HELIX 504..507 FT /evidence="ECO:0007829|PDB:3BB0" FT HELIX 530..532 FT /evidence="ECO:0007829|PDB:3BB0" FT STRAND 538..541 FT /evidence="ECO:0007829|PDB:1IDQ" FT STRAND 542..544 FT /evidence="ECO:0007829|PDB:3BB0" FT HELIX 552..565 FT /evidence="ECO:0007829|PDB:3BB0" FT HELIX 573..575 FT /evidence="ECO:0007829|PDB:3BB0" SQ SEQUENCE 609 AA; 67531 MW; A7B710DDF937D3E9 CRC64; MGSVTPIPLP KIDEPEEYNT NYILFWNHVG LELNRVTHTV GGPLTGPPLS ARALGMLHLA IHDAYFSICP PTDFTTFLSP DTENAAYRLP SPNGANDARQ AVAGAALKML SSLYMKPVEQ PNPNPGANIS DNAYAQLGLV LDRSVLEAPG GVDRESASFM FGEDVADVFF ALLNDPRGAS QEGYHPTPGR YKFDDEPTHP VVLIPVDPNN PNGPKMPFRQ YHAPFYGKTT KRFATQSEHF LADPPGLRSN ADETAEYDDA VRVAIAMGGA QALNSTKRSP WQTAQGLYWA YDGSNLIGTP PRFYNQIVRR IAVTYKKEED LANSEVNNAD FARLFALVDV ACTDAGIFSW KEKWEFEFWR PLSGVRDDGR PDHGDPFWLT LGAPATNTND IPFKPPFPAY PSGHATFGGA VFQMVRRYYN GRVGTWKDDE PDNIAIDMMI SEELNGVNRD LRQPYDPTAP IEDQPGIVRT RIVRHFDSAW ELMFENAISR IFLGVHWRFD AAAARDILIP TTTKDVYAVD NNGATVFQNV EDIRYTTRGT REDPEGLFPI GGVPLGIEIA DEIFNNGLKP TPPEIQPMPQ ETPVQKPVGQ QPVKGMWEEE QAPVVKEAP //